NCT03244384 · Interventional trial
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer
Overall registry status Active not recruiting
Phase 3
Conditions Localized Renal Pelvis and Ureter Urothelial Carcinoma, Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma AJCC v6 and v7, Stage II Renal Pelvis and Ureter Cancer AJCC v7, Stage II Ureter Cancer AJCC v7, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Renal Pelvis and Ureter Cancer AJCC v7, Stage III Ureter Cancer AJCC v7
Delaware Valley sites
- Doylestown Hospital · Doylestown, PA · Bucks County
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
- Temple University Hospital · Philadelphia, PA · Philadelphia County
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
- University of Pennsylvania/Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory